<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-27T04:42:25Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/45162" metadataPrefix="qdc">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/45162</identifier><datestamp>2026-02-05T00:47:50Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37959</setSpec></header><metadata><qdc:qualifieddc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>IGF-II: a neuroprotective agent against Cocaine-induced oxidative stress and apoptosis</dc:title>
   <dc:creator>Zamorano-González, Pablo</dc:creator>
   <dc:creator>Valverde, Nadia</dc:creator>
   <dc:creator>Bandini, Luca</dc:creator>
   <dc:creator>Claros-Gil, Silvia</dc:creator>
   <dc:creator>Romero-Zerbo, Yanina</dc:creator>
   <dc:creator>Lara, Estrella</dc:creator>
   <dc:creator>Santín-Núñez, Luis Javier</dc:creator>
   <dc:creator>García-Fernández, María Inmaculada</dc:creator>
   <dc:creator>Martín-Montañez, Elisa</dc:creator>
   <dc:creator>Gago-Calderón, Belén</dc:creator>
   <dc:subject>Estrés oxidativo</dc:subject>
   <dc:subject>Mitocondrías</dc:subject>
   <dcterms:abstract>Excessive cocaine (benzoylmethylecgonine) consumption has been associated with neurodegenerative diseases affecting dopaminergic neurons, such as Parkinson’s disease (PD). Insulin-like growth factor II (IGF-II) has demonstrated protective effects against oxidative stress induced by neuropathologies and drug exposure. This study evaluates the impact of cocaine on neuronal morphology and viability and investigates IGF-II’s potential neuroprotective role using SN4741 dopaminergic cells.
Cells were exposed for 24 hours to either cocaine alone or cocaine with IGF-II. Cell death (LDH assay) and morphological alterations (Giemsa staining) were assessed, alongside mitochondrial integrity and function (OCR, Seahorse), membrane potential (JC-1), and ROS production (DHE) after 6-hour treatments.
An optimal cocaine concentration (2 mM) was measured, inducing 39.75% neuronal death. IGF-II (1.5 ng/mL), established as effective in previous studies, significantly reduced cocaine-induced cell death (280% increase vs. control). Morphological changes induced by cocaine, including globular shape, membrane thinning, loss of neurites, and cell aggregation, were prevented by IGF-II co-treatment. Cocaine significantly increased ROS levels (173.6%) and reduced mitochondrial membrane potential (20%), both indicative of apoptosis induction. IGF-II effectively reversed these effects, preventing oxidative stress and preserving mitochondrial function. Furthermore, IGF-II mitigated a 60% reduction in mitochondrial oxygen consumption induced by cocaine.
In conclusion, IGF-II exhibits potent antioxidant and neuroprotective properties, counteracting cocaine-induced oxidative stress, mitochondrial dysfunction, and neuronal degeneration. These findings support IGF-II as a potential therapeutic agent against cocaine-related neurotoxicity.</dcterms:abstract>
   <dcterms:issued>2025-09-03</dcterms:issued>
   <dc:type>conference output</dc:type>
   <dc:identifier>https://hdl.handle.net/10630/45162</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>20th Meeting of the Spanish Society for Neuroscience</dc:relation>
   <dc:relation>Las Palmas de Gran Canaria</dc:relation>
   <dc:relation>03/09/2025-05/09/2025</dc:relation>
   <dc:relation>.</dc:relation>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
</qdc:qualifieddc>
</metadata></record></GetRecord></OAI-PMH>